• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protara Therapeutics, Inc. - Common Stock (NQ:TARA)

3.820 -0.340 (-8.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,162,986
Open 4.010
Bid (Size) 3.820 (2,500)
Ask (Size) 3.970 (300)
Prev. Close 4.160
Today's Range 3.790 - 4.055
52wk Range 2.770 - 7.820
Shares Outstanding 11,235,731
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million ↗
May 31, 2026
Mineralys Therapeutics develops novel therapies for resistant hypertension, with its lead candidate advancing through clinical trials. 
Via The Motley Fool
Topics Regulatory Compliance
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 24, 2026
Via Chartmill

Performance

YTD
-29.0%
-29.0%
1 Month
-15.5%
-15.5%
3 Month
-21.2%
-21.2%
6 Month
-28.7%
-28.7%
1 Year
+26.1%
+26.1%

More News

Read More
Tuesday's session: top gainers and losers ↗
February 24, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
February 24, 2026
Via Chartmill
Which stocks are moving before the opening bell on Tuesday? ↗
February 24, 2026
Via Chartmill
News headline image
Does TARA Stock’s 15% After-Hours Slump Signal A Bargain After New Bladder Cancer Data? ↗
February 24, 2026
Via Stocktwits
News headline image
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗
December 05, 2025
Via Chartmill
News headline image
The market is filled with gapping stocks in Friday's session. ↗
December 05, 2025
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
December 05, 2025
Via Chartmill
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
December 04, 2025
Via Chartmill
News headline image
What's Going On With Protara Therapeutics Stock Wednesday? ↗
November 19, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 22, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 28, 2025
Via Benzinga
News headline image
Protara Beats Q2 Loss Estimates ↗
August 11, 2025
Via The Motley Fool
News headline image
These stocks are moving in today's session ↗
April 28, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
April 28, 2025
Via Benzinga
News headline image
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook ↗
April 28, 2025
Via Benzinga
News headline image
Which stocks are gapping on Monday? ↗
April 28, 2025
Via Chartmill
News headline image
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings ↗
April 28, 2025
Via Benzinga
Topics Stocks
News headline image
This H.B. Fuller Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
April 17, 2025
Via Benzinga
News headline image
This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
April 16, 2025
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
December 06, 2024
Via Benzinga
News headline image
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
December 06, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
December 05, 2024
Via Benzinga

Frequently Asked Questions

Is Protara Therapeutics, Inc. - Common Stock publicly traded?
Yes, Protara Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Protara Therapeutics, Inc. - Common Stock trade on?
Protara Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Protara Therapeutics, Inc. - Common Stock?
The ticker symbol for Protara Therapeutics, Inc. - Common Stock is TARA on the Nasdaq Stock Market
What is the current price of Protara Therapeutics, Inc. - Common Stock?
The current price of Protara Therapeutics, Inc. - Common Stock is 3.820
When was Protara Therapeutics, Inc. - Common Stock last traded?
The last trade of Protara Therapeutics, Inc. - Common Stock was at 06/30/26 04:00 PM ET
What is the market capitalization of Protara Therapeutics, Inc. - Common Stock?
The market capitalization of Protara Therapeutics, Inc. - Common Stock is 42.92M
How many shares of Protara Therapeutics, Inc. - Common Stock are outstanding?
Protara Therapeutics, Inc. - Common Stock has 43M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap